Coming May 2025
Get Early Access
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
11.1k employees
Eisai Co., Ltd., a Japanese pharmaceutical firm, produces and markets prescription drugs, medical equipment, and agrochemicals globally.
HQ
Founded
1941
Eisai Co., Ltd. is a Japanese pharmaceutical company focused on producing and marketing prescription drugs, medical equipment, and agrochemicals globally. The company also manufactures diagnostic drugs and sells its products through subsidiaries and related companies in the US, Europe, and Asia.
Eisai has made significant strides in the pharmaceutical industry, contributing to advancements in healthcare through its innovative products. The company's global reach and diverse product offerings have established it as a key player in the market, impacting patient care worldwide.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Pharmaceuticals, Medical Equipment
Technology
Biotech
Model Types
Hardware, Software
Revenue Type(s)
Transactional, Recurring
Customer Type(s)
Consumers, Enterprise
Geographic Exposure
Global
When was Eisai Co. founded?
Eisai Co. was founded in 1941.
Where is Eisai Co.'s headquarters located?
Eisai Co.'s headquarters is located in Tokyo, JP.
How many employees does Eisai Co. have?
Eisai Co. has 11076 employees as of Feb 6, 2024.
Add Comparison
Current Employees
11.1k
Last updated: Feb 6, 2024
No location information available for this company.
Locations
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts